Our Collaborations

Status: Ongoing

The purpose of the Collaborative Working Project is to codesign care pathways for people living with HIV in Cheshire & Merseyside, using insights gathered. The aim is to improve patients’ experience of care, improve their clinical outcomes and improve the retention in care.

Executive Summary

Status: Completed
This Joint Working Project aims to co-design and implement a digital health pathway of care for the delivery of a PROM, ensuring it is person-centred and acceptable from a patient and clinician perspective regarding user experience and flow.

Read more about this project:
Executive summary

Status: Ongoing
The aim of this project is to understand the treatments that DLBCL patients receive from diagnosis, how they are referred for 2L CAR-T therapies and the reasons for the lower-than-expected referral rates in Wales.

Read more about this project:
Executive summary

Status: Ongoing
This collaborative working project between Gilead Sciences Ltd and Western General Hospital, Edinburgh, will provide dedicated resources to a patient-centric CAR T service. It will include setting up a nurse/pharmacy-led clinic, introduce consistent educational programmes for health care professionals, and implement a holistic needs assessment approach to improve the overall patient experience.

Read more about this project:
Executive Summary

Status: Ongoing
This project aims to make available a new iteration of a simulation training program developed by St. George’s Hospital to provide clinicians with practical experience in familiarising themselves with CAR-T patient counselling and management in a mock (simulated) environment.

Read more about this project:
Executive Summary

Status: Ongoing

The purpose of the Collaborative Working Project is to address growing pressures on hepatitis B services by mapping current pathways, identifying gaps, and developing a gold standard pathway to improve diagnosis, access equity, and patient retention. Desired outcomes include universal hepatitis delta testing, re‑engaging patients lost to follow‑up, system‑wide rollout across Cheshire & Merseyside, and national endorsement and dissemination of the pathway.

Status: Ongoing
The purpose of the Collaborative Working Project is to establish a test and treatment pathway to support HCV micro-elimination in the Health Board by optimising the testing, diagnosis and treatment access.

Read more about this project:
Executive Summary

Status: Ongoing
This project aims to micro-eliminate hepatitis C in all drug and alcohol services across NHS Trusts which are part of the NHS Addictions Provider Alliance and to expand benefits across the wider UK region by sharing the considerable expertise that has been built by Hep CU Later and Gilead Sciences Ltd.

Read more about this project:
Executive Summary

Status: Completed
A Joint Working Project between NHS-Forth-Valley (NHSFV) and Gilead Sciences Ltd. aims to support the Scottish Government's target of hepatitis C elimination by 2025.

Read more about this project:
Executive Summary

Status: Completed
This initiative is led by the NHS Addictions Provider Alliance (formally the NHS Substance Misuse Alliance) and is a Joint Working agreement with Gilead Sciences Ltd. The aim is to micro-eliminate hepatitis C within the drug and alcohol services of the NHS Addictions Provider Alliance.

Read more about this project:
Impact Report - Year 1
Impact Report - Year 2

The extension aims to improve prevention, case finding, and treatment of hepatitis B and D, supporting WHO and NHS England goals.
It will target general practice and the public, with resources available to a wide range of stakeholders.

Read more about this project:
Executive Summary